SILVERARC CAPITAL MANAGEMENT, LLC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1816307 BOSTON, MA

Position in RYTM

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$26,612,820

+$12,060,732 QoQ

Shares Held

306,000

+125.1% QoQ

Ownership

0.447%

of shares outstanding

% of Portfolio

3.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SILVERARC CAPITAL MANAGEMENT, LLC holds $782,503,784 across 55 Biotechnology names. RYTM ranks #13 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KALV	KalVista Pharmaceuticals, Inc.	2,876,407	$57,902,072
2	DNTH	Dianthus Therapeutics, Inc. /DE/	654,746	$54,946,284
3	COGT	Cogent Biosciences, Inc.	1,314,189	$50,583,134
4	CELC	Celcuity Inc.	357,903	$40,851,048
5	IMNM	Immunome Inc.	1,850,278	$40,465,579
6	KOD	Kodiak Sciences Inc.	991,930	$37,812,371
7	NUVL	Nuvalent, Inc.	354,914	$36,360,939
8	ABVX	Abivax S.A.	302,530	$33,686,715

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$26,612,820	306,000	+125.1%	Shares	Sole	2026-05-14
2025-12-31	$14,552,088	135,950	-63.3%	Shares	Sole	2026-02-12
2025-09-30	$37,365,896	369,996	-7.7%	Shares	Sole	2025-11-12
2025-06-30	$25,324,782	400,772	+18.7%	Shares	Sole	2025-08-14
2025-03-31	$17,882,936	337,605	+23.3%	Shares	Sole	2025-05-14
2024-12-31	$15,332,698	273,896	+7.2%	Shares	Sole	2025-02-14
2024-09-30	$13,389,731	255,578	+38.4%	Shares	Sole	2024-11-14
2024-06-30	$7,582,221	184,662	+0.5%	Shares	Sole	2024-08-14
2024-03-31	$7,963,014	183,776	+5.5%	Shares	Sole	2024-05-15
2023-12-31	$8,010,180	174,248	-33.1%	Shares	Sole	2024-02-14
2023-09-30	$5,972,810	260,537	+124.3%	Shares	Sole	2023-11-13
2023-06-30	$1,915,610	116,168	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.